Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multimodal Quantitative MR Imaging of the Thalamus in Multiple Sclerosis and Neuromyelitis Optica.
(18)F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report.
Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values.
Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration.
Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.
Structural equation modeling of factors contributing to quality of life in Japanese patients with multiple sclerosis.
Benchmarks of meaningful impairment on the MSFC and BICAMS.
Unilateral optic neuritis, scleritis and exudative retinal detachment due to recurrent orbital pseudotumor.
Mitochondrial and nuclear genes as the cause of complex I deficiency.
New data presented at 29th ECTRIMS congress reinforce the clinical profile of investigational laquinimod on disease progression and inflammation in relapsing-remitting multiple sclerosis
Contribution of genome-wide association studies to scientific research: a pragmatic approach to evaluate their impact.
Therapeutic plasma exchange in neuromyelitis optica: A case series.
Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.
Quantitative Proteomic Analysis of Human Substantia Nigra in Alzheimer's Disease, Huntington's Disease and Multiple Sclerosis.
Multiple sclerosis: Spinal cord MRI indices correlate with outcome in MS.
Emerging Subspecialties in Neurology: Palliative care.
Natalizumab (BG00002) Re-Initiation of Dosing. (STRATA)
Downregulation of cystathionine β-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type.
Central Neuropathic Pain Syndromes.
Perspectives on Physical Activity Among People with Multiple Sclerosis Who Are Wheelchair Users: Informing the Design of Future Interventions.
Exercise in the community for people with minimal gait impairment due to MS: an assessor-blind randomized controlled trial.
Neuromyelitis optica.
Alemtuzumab for multiple sclerosis: a new age of immunotherapy.
Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine.
Factors for lower walking speed in persons with multiple sclerosis.

Pages